# OnCo record degarelix (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/degarelix/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "degarelix" ;
  schema:name "Degarelix"@en ;
  schema:description "An injectable hormone blocker for prostate cancer that lowers testosterone within days without the initial surge caused by agonists."@en ;
  schema:url <https://onco.cc/drugs/degarelix/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Degarelix> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1182795> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=degarelix>, <https://www.nice.org.uk/guidance/ta404> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "GnRH antagonist depot" ;
  schema:alternateName "Firmagon" ;
  onco:approval "US 2008: Advanced prostate cancer", "EU 2009: Same" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/ferring/> ;
  onco:terms <https://onco.cc/terms/prostate-adt-burden/>, <https://onco.cc/terms/prostate-uk-drug-approvals/> ;
  onco:trials <https://onco.cc/trials/nct02663908/>, <https://onco.cc/trials/nct00833248/>, <https://onco.cc/trials/nct00884273/> .